ELTP insider filings

ELITE PHARMACEUTICALS INC /NV/ — 32 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-09. Screen ELTP transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Dash Barry H — Director22 legs · 130,000 sh · $34,590——
FATMI AQEEL AHMAD — Director1———
LaRocca John — Director1———

Recent insider filings — ELITE PHARMACEUTICALS INC /NV/

FiledFormInsiderReported transactionsSource
2026-11-093FATMI AQEEL AHMAD — DirectorHoldings only — no transactions reportedEDGAR
2026-11-063LaRocca John — DirectorHoldings only — no transactions reportedEDGAR
2026-10-194Dash Barry H — DirectorPurchase (P): 100,000 @ $0.26EDGAR
2026-09-104Dash Barry H — DirectorPurchase (P): 30,000 @ $0.29EDGAR
2026-01-134Plassche Douglas — EVP OperationsOption exercise (M): 2,500,000 @ $0.03 · Option exercise (M): 2,500,000 (derivative) @ $0EDGAR
2025-10-034Plassche Douglas — EVP OperationsSale (S): 800,000 @ $0.62EDGAR
2025-08-264ELITE PHARMACEUTICALS INC /NV/ — EVP OperationsSale (S): 500,000 @ $0.52 · Option exercise (M): 2,500,000 @ $0.03 · Option exercise (M): 2,500,000 (derivative) @ $0EDGAR
2025-07-254Kirkov Kirko — Chief Commercial OfficerPurchase (P): 16,366 @ $0.59EDGAR
2025-07-104Plassche Douglas — EVP OperationsSale (S): 200,000 @ $0.58EDGAR
2025-07-084Plassche Douglas — EVP OperationsOption exercise (M): 2,500,000 @ $0.03 · Option exercise (M): 2,500,000 (derivative) @ $0EDGAR
2024-10-284Plassche Douglas — SVP of OperationsSale (S): 800,000 @ $0.49 · Sale (S): 333,932 @ $0.51EDGAR
2024-04-024Hakim Nasrat A — CEO, President, Director, 10% ownerGrant/award (A): 49,534,368 @ $0EDGAR
2024-04-024/AHakim Nasrat A — CEO & President, Director, 10% ownerHoldings only — no transactions reportedEDGAR
2023-12-294Hakim Nasrat A — CEO, President, Director, 10% ownerGrant/award (A): 2,223,147 @ $0.07EDGAR
2023-11-274WHITNELL JEFFREY A — DirectorGrant/award (A): 547,657 @ $0.04EDGAR
2023-11-274Caskey Davis S — DirectorGrant/award (A): 547,657 @ $0.04EDGAR
2023-11-274Dash Barry H — DirectorGrant/award (A): 547,657 @ $0.04EDGAR
2023-06-264Plassche Douglas — Executive VP OperationsGrant/award (A): 7,500,000 (derivative) @ $0.03EDGAR
2022-11-144Kirkov Kirko — Chief Commercial OfficerGrant/award (A): 3,000,000 (derivative) @ $0.04EDGAR
2022-08-294WHITNELL JEFFREY A — DirectorGrant/award (A): 459,536 @ $0.04EDGAR
2022-08-294Caskey Davis S — DirectorGrant/award (A): 459,536 @ $0.04EDGAR
2022-08-294Dash Barry H — DirectorGrant/award (A): 459,536 @ $0.04EDGAR
2022-07-074Chen Robert C J — CFO, Secretary, TreasurerGrant/award (A): 900,000 (derivative) @ $0.04EDGAR
2021-07-074Bregman Marc — CFO, Secretary, TreasurerGrant/award (A): 300,000 (derivative) @ $0.06EDGAR
2021-07-014WHITNELL JEFFREY A — DirectorGrant/award (A): 295,570 @ $0.07EDGAR
2021-07-014Caskey Davis S — DirectorGrant/award (A): 295,570 @ $0.07EDGAR
2021-07-014Dash Barry H — DirectorGrant/award (A): 295,570 @ $0.07EDGAR
2020-08-264Hakim Nasrat A — CEO & President, Director, 10% ownerConversion (C): 158,017,321 @ $0 · Conversion (C): 24.03 (derivative) @ $0EDGAR
2020-08-244Plassche Douglas — SVP OperationsGrant/award (A): 71,739 @ $0.09EDGAR
2020-08-244Caskey Davis S — DirectorGrant/award (A): 516,781 @ $0.09EDGAR
2020-08-244WHITNELL JEFFREY A — DirectorGrant/award (A): 516,781 @ $0.09EDGAR
2020-08-244Dash Barry H — DirectorGrant/award (A): 516,781 @ $0.09EDGAR

Recent 8-K events — ELITE PHARMACEUTICALS INC /NV/

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-118-K/A7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-298-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-238-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-158-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ELTP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs